Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03853005
Other study ID # 28503011700371A1
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 15, 2019
Est. completion date April 28, 2019

Study information

Verified date March 2019
Source Assiut University
Contact Ayman A Glala, Ass.lecturer
Phone 00201025675901
Email Aymanglala24@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate improvement of sepsis patients with a new modality of treatment (HDF)


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date April 28, 2019
Est. primary completion date April 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. = 18 years

2. Severe sepsis defined by Quick SOFA score by presentation of 2 or more of the following criteria:

- Mental clouding: decreased glasco coma scale GCS < 15

- Hypotension: Systolic blood pressure < 100 mmgH

- Tachypnea: respiratory rate > 22 breath/ minute Then serum lactate is analysed to confirm sepsis hypoperfusion if = 2mmol/L

3. Organs dysfunction (including one of them respiratory failure).

Organ dysfunctions are defined as following:

Respiratory dysfunction (criteria for ARDS):

- PaO2/FiO2 <200

- Bilateral infiltrates in chest X-ray

- Resistant hypoxemia

- Tachypnoea (RR > 40 breath/minute)

- The need for invasive mechanical ventilation

- Excluded cardiac causes of pulmonary edema

CNS failure:

- Decreased GCS = 4 decreased points

CVS dysfunction:

- Sustained hypotension even on very high inotropes doses (Noradrenaline >1µm/min)+ adrenaline>1.5µm/min associated

- with high CVP pressure > 12 mmHg and not responding to fluid challenge test to exclude hypovolemia.

- Cardiomegaly detected by either echocardiography assessment, or chest X-ray

- Resistant frequent ventricular ectopics not explained by organic causes.

Liver dysfunction:

- Elevated total and direct bilirubin than double normal or basal levels

- Elevated prothrombin time > 17 seconds or INR > 1.5

- Elevated liver enzymes > triple normal level

Renal dysfunction:

- Decreased urine output < 0.5 ml/kg.

- Elevated creatinine level > 164 µmol/L (1.5mg/dL).

- Decreased creatinine clearance <50ml/minute if available.

Bone marrow depression:

- Decreased platelets < 90 X 103/µL

- Decreased leukocytes <4 X 103/µL

- Decreased RBCs count < 4 X 106/µL

Exclusion Criteria:

1. Patient relatives' refusal

2. Pregnancy

3. Recent active internal hemorrhage

4. Not mechanically ventilated.

5. Hypersensitivity to the dialyser fluid

Study Design


Related Conditions & MeSH terms


Intervention

Other:
HVHDF
Patients will receive HVHDF treatment for at least 48 hours. HVHDF will be performed via indwelling central venous catheter. The blood flow will be 180-240 ml/min, and ultrafiltration rate will be 35-50 ml/kg/h during HVHF. The substitute fluid will be infused with pre-dilution. Heparin will be used for anti-coagulation, whose initial dose will be 15-25 U/kg, and maintenance dose is 5-15 U/kg/h. aPTT time maintained between 60-80 second and will be checked every 12 hours.
controlled
supportive care

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Arterial oxygen pressure change in arterial oxygen pressure (PO2) in units of millimeter mercury (mmHg) at 0 hour, 24hours and after completion of 48 hours
Secondary lung mechanics change in compliance (ml/cmH2O) 0, 24, and 48 hours
Secondary inflammatory biomarkers Measure inflammatory biomarkers: Interleukin-6. 0, 24, and 48 hours
See also
  Status Clinical Trial Phase
Completed NCT00753129 - Head Elevation in Prone Position Phase 2
Recruiting NCT06125665 - Aminophylline on Perioperative Lung Mechanics in COPD Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery N/A
Completed NCT06433076 - The Association Between Respiratory Effort Parameters During the First 48 Hours With Clinical Outcomes in Mechanically Ventilated Patients: A Prospective Observational Study.